[Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)]
[Senate]
[Page S1301]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1216. Ms. ROSEN submitted an amendment intended to be proposed by 
her to the concurrent resolution S. Con. Res. 7, setting forth the 
congressional budget for the United States Government for fiscal year 
2025 and setting forth the appropriate budgetary levels for fiscal 
years 2026 through 2034; which was ordered to lie on the table; as 
follows:

       At the appropriate place in title IV, add the following:

     SEC. 4___. POINT OF ORDER AGAINST INCREASING THE COST OF 
                   PRESCRIPTION DRUGS.

       (a) Point of Order.--It shall not be in order in the Senate 
     to consider any bill, joint resolution, motion, amendment, 
     amendment between the Houses, or conference report that would 
     increase the cost of prescription drugs, including by 
     repealing the $35 insulin cap for Medicare beneficiaries, 
     increasing out-of-pocket costs for Medicare beneficiaries, or 
     increasing drug costs for Medicaid patients, patients with 
     private health insurance, patients covered by TRICARE, or 
     uninsured patients.
       (b) Waiver and Appeal.--Subsection (a) may be waived or 
     suspended in the Senate only by an affirmative vote of three-
     fifths of the Members, duly chosen and sworn. An affirmative 
     vote of three-fifths of the Members of the Senate, duly 
     chosen and sworn, shall be required to sustain an appeal of 
     the ruling of the Chair on a point of order raised under 
     subsection (a).
                                 ______